Particle engineering/different film approaches for earlier absorption of meloxicam

References

• Abd El-bary A, Foda N, Elkhateeb M. (2001). Reversed phase liquid chromatographic determination of meloxicam in human plasma and its pharmacokinetic application. Anal Lett 34:1175–87
   Web of Science ®Google Scholar
• Ahmed M, Khanna D, Frust DE. (2005). Meloxicam in rheumatoid arthritis. Expert Opin Drug Metab Toxicol 1:739–51
   PubMedGoogle Scholar
• Bhanja SB, Ellaiah P, Martha SK, et al. (2010). Buccoadhesive drug delivery system of captopril: formulation and in vitro evaluation. J Pharm Res 3:335–40
   Google Scholar
• British Pharmacopoeia III. (2003). London: Her Majesty's Stationery Office Ltd, 2598–9
   Google Scholar
• Dahiya M, Saha S, Sahiwala A. (2009). A review on mouth dissolving films. Curr Drug Deliv 6:469–76
   PubMedGoogle Scholar
• Davies NM, Skjodt NM. (1999). Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clin Pharmacokinet 36:115–26
   PubMed Web of Science ®Google Scholar
• Di Martino P, Barthélémy C, Piva F, et al. (1999). Improved dissolution behavior of fenbrufen by spherical crystallization. Drug Dev Ind Pharm 25:1073–81
   PubMed Web of Science ®Google Scholar
• Dixit M, Kulkarni PK, Selvam RP, et al. (2011). Preparation and characterization of spherical agglomerates of piroxicam by neutralization method. Am J Drug Discov Devel 1:188–99
   Google Scholar
• Dixit RP, Puthli SP. (2009). Oral strip technology: overview and future potential. J Control Release 139:94–107
   PubMed Web of Science ®Google Scholar
• El-Setouhy DA, Abd El-Malak NS. (2010). Formulation of a novel tianeptine sodium orodispersible films. AAPS Pharm Sci Tech 11:1018–25
   PubMed Web of Science ®Google Scholar
• Euller-Ziegler L, Vélicitat P, Bluhmki E, et al. (2001). Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration. Inflamm Res 50:S5–9
   PubMed Web of Science ®Google Scholar
• Farid M, El-Setouhy DA, El-Nabarawi MA, El-Bayomi T. (2014). Recrystallized agglomerated meloxicam: evaluation of anti-nociceptive effect. J Drug Deliv Sci Tec, accepted for publication
   Web of Science ®Google Scholar
• Fawzia H, Abdel Azeem M, Gihan F, Mohamed S. (2010). Mucoadhesive buccal patches of lornoxicam: i-development and in-vitro characterization. Bull Pharm Sci, Assiut University 33:59–68
   Web of Science ®Google Scholar
• Goldman AP, Williams CS, Sheng H, et al. (1998). Meloxicam inhibits the growth of colorectal cancer cells. Carcinogenesis 19:2195–9
   PubMed Web of Science ®Google Scholar
• Hanft G, Türck D, Scheuerer S, Sigmund R. (2001). Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations. Inflamm Res 50:535–7
   Web of Science ®Google Scholar
• Hoffmann EM, Breitenbach A, Breitkreutz J. (2011). Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv 8:299–316
   PubMed Web of Science ®Google Scholar
• Kulmatycki KM, Jamali F. (2007). Drug disease interactions: role of inflammatory mediators in pain and variability in analgesic drug response. Int J Pharm Pharm Sci 10:554–66
   Web of Science ®Google Scholar
• Kürti L, Kukovecz Á, Kozma G, et al. (2011). Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles. Powder Technol 212:210–17
   Web of Science ®Google Scholar
• Laska EM, Sunshine A, Marrero I, et al. (1986). The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 40:1–7
   PubMed Web of Science ®Google Scholar
• Liang AC, Chen LH. (2001). Fast-dissolving intraoral drug delivery systems. Expert Opin Ther Pat 11:981–6
   Web of Science ®Google Scholar
• Lobenberg R, Amidon GL. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 50:3–12
   PubMed Web of Science ®Google Scholar
• Lucas SF, Anagha B, Jackeline I, et al. (2012). Preparation and characterization of hdroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications. Int J Pharm 423:496–508
   PubMed Web of Science ®Google Scholar
• Luger P, Daneck K, Engel W, et al. (1996). Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci 4:175–87
   Web of Science ®Google Scholar
• Maghsoodi M, Taghizadeh O, Martin GP, Nokhodchi A. (2008). Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Int J Pharm 2351:45–54
   Web of Science ®Google Scholar
• Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. (2005). Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm 31:25–34
   PubMed Web of Science ®Google Scholar
• Najib NM, Suleiman M, Malak A. (1986). Characteristics of the in-vitro release of ibuprofen from polyvinylpyrrolidone solid dispersion. Int J Pharm 32:229–36
   Web of Science ®Google Scholar
• Naruse T, Nishida Y, Hosono K, Ishiguro N. (2006). Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2 dependent and independent routes. Carcinogenesis 27:584–92
   PubMed Web of Science ®Google Scholar
• Patel R, Naik S, Baria A. (2009). Formulation development and evaluation of mouth melting film of ondansetron. Arch Pharm Sci Res 1:121–7
   Google Scholar
• Prabhakara P, Ravi M, Marina K, et al. (2011). Formulation and evaluation of fast dissolving films of levocitirizine dihydrochloride. Int J Pharm Investig 1:99–104
   PubMedGoogle Scholar
• Rebecca A, Kinam P, Alyssa P. (2013). Water soluble polymer films for intravascular drug delivery of antithrombotic biomolecules. Eur J Pharm Biopharm 84:125–31
   PubMed Web of Science ®Google Scholar
• Shimoda H, Taniguchi K, Nishimura M, et al. (2009). Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Biopharm 73:361–5
   PubMed Web of Science ®Google Scholar
• Tomar A, Sharma K, Chauhan NS, et al. (2012). Formulation and evaluation of fast dissolving oral film of dicyclomine as potential route of buccal delivery. Int J Drug Dev Res 4:408–17
   Google Scholar
• Usha AN, Mutalik S, Reddy MS, et al. (2008). Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. Eur J Pharm Biopharm 70:674–83
   PubMed Web of Science ®Google Scholar